Could THIS CAR-T Therapy Change Lymphoma Treatment Forever?

0 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In this groundbreaking video, we explore the revolutionary potential of HSP-CAR30, a novel CAR-T therapy that could change the face of lymphoma treatment forever. Researchers at Sant Pau Research in Barcelona, led by the esteemed Josep Carreras, have made a significant breakthrough in the phase I trial of this innovative immunotherapy. By harnessing the power of memory T cells, HSP-CAR30 has shown remarkable promise in achieving cancer remission for patients with Hodgkin lymphoma and CD30 lymphoma. This lymphoma breakthrough has the potential to transform the field of hematology and oncology, offering new hope to those affected by this devastating disease. Join us as we delve into the latest developments in CAR-T therapy and uncover the possibilities of this game-changing treatment.
Category
Oncology
Be the first to comment

Up Next